Regulatory Recognition in One of Asia’s Most Demanding Markets
Affron®, Pharmactive’s standardized saffron extract, has been granted individual functional ingredient recognition by South Korea’s Ministry of Food and Drug Safety (MFDS) for use in products positioned for stress support.
This regulatory recognition represents an important step in Affron®’s international development and reflects the completion of a comprehensive scientific evaluation under Korea’s Health Functional Food framework.
Products formulated with Affron® may qualify to bear the official Health Functional Food (HFF) seal, subject to compliance with local regulatory requirements.
Understanding Korea’s Individual Recognition System
South Korea applies a highly structured regulatory pathway for ingredients seeking functional health positioning. Under the MFDS system, ingredients not included in the standard positive list must undergo individual scientific assessment.
The submission process requires extensive documentation, typically including:
-
Human clinical data relevant to the proposed use
-
Identified biomarkers and proposed mechanisms
-
Toxicological safety evaluation
-
Analytical characterization and batch consistency data
-
Stability documentation
The evaluation pathway for Affron® extended over a multi-year period and included the review of chemical fingerprinting, manufacturing controls, and the full body of available preclinical and clinical research.
Scientific Dossier Supporting Affron®
Affron® is supported by a portfolio of 12 human clinical studies involving more than 1,000 participants across different population groups.
Several trials have explored parameters related to stress and mood support. Pharmacokinetic research has provided data consistent with the bioavailability of crocetin, a saffron-derived metabolite.
Preclinical investigations, including an in vivo study conducted in Korea, have contributed mechanistic insights into pathways associated with stress-response biology. Observed findings included changes in biomarkers linked to the hypothalamic–pituitary–adrenal (HPA) axis.
Affron® is standardized to Lepticrosalides® and manufactured using a solvent-free extraction process designed to preserve saffron’s key bioactive constituents while maintaining analytical consistency.
South Korea as a Strategic Nutraceutical Hub
South Korea is widely regarded as one of the most regulated and innovation-driven nutraceutical markets in Asia.
The country’s Health Functional Food sector continues to expand, with stress-management and sleep-related categories showing sustained growth. Regulatory recognition by the MFDS is considered a significant validation step within this ecosystem.
Through collaboration with Hyundai Bioland Co., Ltd., Pharmactive successfully navigated the regulatory pathway, supporting the introduction of Affron® into the Korean functional ingredient landscape.
Expanding International Regulatory Footprint
The individual recognition granted in South Korea contributes to Affron®’s broader regulatory portfolio and reflects Pharmactive’s long-term commitment to scientific documentation, analytical definition, and regulatory compliance.
By aligning product development with structured regulatory frameworks, Pharmactive continues advancing its global botanical ingredient strategy.
